A Prospective Study Comparing Infection Risk and Disease Activity in Children With Juvenile Idiopathic Arthritis Treated With and Without Tumor Necrosis Factor-Alpha Inhibitors

Clinical Rheumatology - United Kingdom
doi 10.1007/s10067-014-2779-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis

JAMA Dermatology
DermatologyMedicine
2013English

Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis

Journal of Pediatric Gastroenterology and Nutrition
Child HealthPediatricsPerinatologyGastroenterology
2016English

Epidemiology in Paediatric Non‐infectious Uveitis Treated With Tumor Necrosis Factor‐alpha Inhibitors: A Retrospective Study

Acta Ophthalmologica
MedicineOphthalmology
2018English

Serious Adverse Events Associated With Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in a Real-Life Setting

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2017English

Trends in Paediatric Rheumatology Referral Times and Disease Activity Indices Over a Ten-Year Period Among Children With Juvenile Idiopathic Arthritis: Results From the Childhood Arthritis Prospective Study

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Predictors of Treatment Initiation With Tumor Necrosis Factor-Α Inhibitors in Patients With Rheumatoid Arthritis

Journal of Managed Care Pharmacy
2014English

Clinical and MRI Outcome of Cervical Spine Lesions in Children With Juvenile Idiopathic Arthritis Treated With Anti-TNFα Drugs Early in Disease Course

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2017English

Tumor Necrosis Factor Alpha in Inflammatory Bowel Disease.

Gut
Gastroenterology
1994English

Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy